Gregory Piazza Presents HI-PRO Trial Results on VTE at ESC Congress
Gregory Piazza, Director of the Vascular Medicine Section at Brigham and Women’s Hospital, posted on LinkedIn:
‘‘Venous thromboembolism (VTE) has traditionally been categorized as unprovoked and treated with extended anticoagulation or provoked and prescribed time-limited anticoagulation for 3 months.
What do we do with patients who have provoked events but other persistent risk factors like obesity or heart disease?
We answered this question in the HI-PRO randomized controlled trial presented in Madrid at the European Society of Cardiology Congress and simultaneously published in the New England Journal of Medicine.
The culmination of 5 years of blood, sweat, and almost tears, it would not have been possible without an amazing team, my co-investigators and the Thrombosis Research Group team!”
Watch the full video here.
Read the full article in NEJM.
Article: Apixaban for Extended Treatment of Provoked Venous Thromboembolism
Authors: Gregory Piazza, Behnood Bikdeli, Arvind Pandey, Darsiya Krishnathasan, Candrika Khairani, Antoine Bejjani, Ruth Morrison, Heather Hogan, Sina Rashedi, Mariana Pfeferman, Junyang Lou, John Fanikos, Nicole Porio, Lisa Rosenbaum, Piotr Sobieszczyk, Zhou Lan, Marie Gerhard-Herman, Umberto Campia, Samuel Goldhaber
Stay updated on all scientific advances in the field of thrombosis with Hemostasis Today.
-
Aug 11, 2026, 08:20Hasan Abbas Zaheer: Strengthening Universal Access to Safe Blood in Pakistan
-
Aug 11, 2026, 08:07Nicola Pozzi: Advancing Hemostasis Through Scientific Collaboration at Hemostasis GRC
-
Aug 11, 2026, 07:50When Access to Care Changes Everything – WFH
-
Aug 11, 2026, 07:41Kevin Land: How Cellular Therapy Is Changing Transfusion Medicine
-
Aug 11, 2026, 07:35Kuldeep Singh Bhadauria: Building the Future of Hemophilia Care in India
-
Aug 11, 2026, 07:28Archil Jaliashvili: When Every Minute Matters Time Becomes a Therapy
-
Aug 11, 2026, 07:05Mavis Agnes Kisakye: Building Sustainable Transition Pathways in Hemophilia Care
-
Aug 11, 2026, 06:48Rishdha Roshad: What Happens to the Brain During Cardiopulmonary Bypass?
-
Aug 11, 2026, 05:53Isaac Okello: Strengthening Sickle Cell Advocacy in Uganda